心肺运动试验衍生评分在特发性肺纤维化与结缔组织病相关间质性肺病中的预后价值:前瞻性队列研究
该前瞻性队列研究纳入2018至2022年间新诊断的210例间质性肺病患者,评估心肺运动试验衍生 summed score 与全因死亡或肺移植复合结局的关联。由5个CPET变量构成的评分是复合结局的独立预测因子,评分2-5分患者无事件生存率(44.2%)显著低于0-1分患者(88.3%),且在IPF和CTD-ILD中预测价值一致。
要点
- CPET衍生summed score可预测新诊断ILD患者的全因死亡或肺移植。
- 评分2-5分者无事件生存率44.2%,显著低于0-1分者的88.3%。
- 该评分在IPF和CTD-ILD中均保持预测准确性。
核心结论
- CPET衍生summed score是预测新诊断ILD患者全因死亡或肺移植需求的有用预后工具。
- 该评分在IPF和CTD-ILD患者中均保持对长期结局的预测准确性。
研究设计与样本
- 前瞻性队列研究,纳入2018至2022年单中心新诊断的210例ILD患者,均接受CPET。
- 评估CPET衍生summed score与全因死亡或肺移植复合结局的关联,采用Cox回归和ROC曲线分析。
- 采用Kaplan-Meier生存分析和log-rank检验比较IPF与CTD-ILD患者的无事件生存率。
主要发现
- 包含5个CPET衍生变量的summed score是复合结局的独立预测因子。
- 评分2-5分患者无事件生存率为44.2%,低于评分0-1分患者的88.3%。
- 该评分在IPF和CTD-ILD中均显示一致的预测价值。
关键数值与推荐
- summed score由5个CPET衍生变量构成。
- 评分2-5分者无事件生存率44.2%,评分0-1分者88.3%。
临床怎么用
- 对新诊断ILD患者可考虑采用CPET衍生summed score进行预后分层。
- 评分较高(2-5分)提示无事件生存率较低,可能需要更密切随访或评估肺移植时机。
局限性
- 需在其他ILD亚型中进行外部验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND OBJECTIVE: Our previous study demonstrated that a summed score derived from six cardiopulmonary exercise testing (CPET) parameters could predict 1-year mortality in patients with interstitial lung disease (ILD). However, its long-term prognostic value across different ILD aetiologies remains unclear. This study aimed to assess the predictive performance of CPET-derived parameters for long-term outcomes in patients with idiopathic pulmonary fibrosis (IPF) and connective tissue disease-associated ILD (CTD-ILD). METHODS: In this prospective cohort study, 210 patients newly diagnosed with ILD between 2018 and 2022 at a tertiary medical centre underwent CPET. A CPET-derived summed score was evaluated for its association with a composite outcome of all-cause mortality or lung transplantation. Cox regression and receiver operating characteristic curve analyses were used to examine predictive ability and identify the optimal cutoff value. Kaplan-Meier survival analysis and log-rank tests compared event-free survival in IPF and CTD-ILD patients. RESULTS: A summed score incorporating five CPET-derived variables was an independent predictor of the composite outcome. Patients with scores of 2-5 had markedly lower event-free survival (44.2%) than those with scores of 0-1 (88.3%). The score demonstrated consistent predictive value in both IPF and CTD-ILD. CONCLUSION: The CPET-derived summed score is a useful prognostic tool for predicting all-cause mortality or the need for lung transplantation in newly diagnosed ILD patients. It also retains predictive accuracy for long-term outcomes in both IPF and CTD-ILD. External validation in other ILD subtypes is warranted. TRIAL REGISTRATION: ClinicalTrials.gov identifier: NCT06476470.
引用
- Tsai YL, Chang KM, Chin CS, et al. Prognostic Value of a Cardiopulmonary Exercise Testing-Derived Summed Score in Idiopathic Pulmonary Fibrosis and Connective Tissue Disease-Associated Interstitial Lung Disease: A Prospective Cohort Study. Respirology. 2025. PMID: 41431164. doi:10.1002/resp.70193
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。